2021 Pharmacy Benefits Conference: Medical Stop Loss – Recent and Ongoing Impact of COVID-19, Specialty Drug and Orphan Therapies
Published: March 24, 2021
• Discover current market conditions for medical stop loss, including premium levels, deductible election and renewal increases.
• Understand observed impact of COVID-19 on stop-loss claims, including actual claims, as well as the potential short-term reduction due to a decline in both elective and necessary procedures. What is the anticipated claim impact on their return, if not from avoided care?
• See the evolving stop-loss claim impact from high-dollar specialty and orphan therapies.
• Hear best practice in both health plan management and stop-loss coverage to ensure proper clinical authorization, administration of therapy and accordingly – prompt stop-loss reinsurance of the related expense.
Ryan Siemers, CEBS, Principal, Aegis Risk